Respiratory failure & ventilation

High-Flow or Standard Oxygen in Acute Hypoxemic Respiratory Failure

N Engl J MedPublished Randomised controlled trial

Primary result · MortalityResult — go to the resultDifference −0.05 percentage points 95% CI −4.21 to 4.10

Authors' conclusion

Among patients with acute hypoxemic respiratory failure, the use of oxygen delivered through a high-flow nasal cannula did not significantly reduce mortality at day 28.

Study context

Population
Patients with acute hypoxemic respiratory failure (PaO2:FiO2 ≤200, respiratory rate >25 breaths/min, pulmonary infiltrate on chest imaging)1,110 analysed
Participants
1,116 patients
Comparison
High-flow nasal cannula oxygen vs standard oxygen therapy
  • High-flow oxygenn = 556
  • Standard oxygenn = 554reference
Primary endpoint
Death
Follow-up
Day 28
Methodological detailsmulticentre, open-label
  • Multicentre
  • Open-label

Primary result

Mortality

Difference

−0.05 percentage points

95% CI −4.21 to 4.10

P = 0.98

Events by treatment group

High-flow oxygen vs Standard oxygen
difference −0.05 percentage points (95% CI −4.21 to 4.10); P = 0.98

As reported in the abstract

Further findings

OutcomeHigh-flow oxygenStandard oxygenDifference (percentage points) (95% CI)
Intubation · day 2842.4%48.4%−5.93 (−11.78 to −0.08)

Safety

Serious adverse events (cardiac arrest or pneumothorax) during spontaneous breathing

Original publication

High-Flow or Standard Oxygen in Acute Hypoxemic Respiratory Failure. N Engl J Med. Published 17 March 2026. doi:10.1056/nejmoa2516087

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.